Experts weigh in on issues that are still unresolved.
on the fumbles and mishaps that led to a delay in response to the formula crisis. A number of reasons were listed, including outdated data systems, insufficient emergency response systems capable of managing multiple public health emergencies, and lack of consumer education on how to handle and prepare infant formula.
Ferry stresses that when you look at the contamination, you have to ask what was first exposed and where. She says thewas not directly found in any of the recalled items—making it possible that the product was exposed to bacteria from other environmental conditions or handling rather than a contaminated ingredient.
Among the FDA’s suggested areas of improvement, Martinello says it is important to create a system to makecases a reportable disease where states can identify infections. Doing so will help better understand the frequency of cases and allow more opportunities for scientists to study the bacteria.Infant formula is regulated as a food product, but experts agree it’s a life-saving item for babies under six months, when milk is the primary source of nutrition.
Ferry says the only alternative to safely and adequately feed a baby under six months when infant formulas aren’t available is breast milk. However, she points out that often people choose infant formula because breastfeeding is not an option for all caregivers. Another possibility is to find other brands of infant formulas, although that is less of an option for infants with special needs.
Production at Abbott’s Michigan plant resumed in early July. Currently, the FDA is forming groups that will work on improving the gaps uncovered in the baby shortage investigation and will reevaluate their progress in a year.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nobody was into NyQuil chicken until the FDA made it a thingAn internet joke has turned into an actual trend thanks to an FDA warning
Read more »
FDA makes it easier for harm reduction groups to purchase lifesaving naloxoneThere are still other barriers to access.
Read more »
Meet Daxxify, a New Botox Alternative That Was Just Approved by the FDAIt promises longer-lasting results than other injectables on the market.
Read more »
Deal reached to renew funding for key FDA programsSenate and House health committee leaders reached an agreement to renew programs that fund key FDA programs for another five years.
Read more »
Here's what the FDA says contributed to the baby formula shortage crisisAn FDA internal review listed more than a dozen factors contributing to the national baby formula shortage earlier this year — but couldn't find a 'single action' to explain why the crisis occurred.
Read more »
FDA aims to boost access to life-saving overdose drug Naloxone -SAN DIEGO (KUSI) – The food and drug administration put out guidance Sept. 22 aimed at boosting access to the lifesaving overdose drug Naloxone. The change is meant to help harm-reduction programs more easily access the opioid antidote by making them exempt from certain FDA rules. The American Medical Association said the new guidance provides more clarity for those organizations...
Read more »